# Orqis Medical Corporation

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/orqis-medical

- Industry: Medical Devices & Equipment
- Headquarters: Lake Forest, US
- Website: www.orqis.com
- Total disclosed funding: $60M
- Latest round: Series D (Mar 26, 2007)
- Investors on record: 13

## About

Orqis Medical Corporation is a medical device company specializing in innovative solutions for heart failure management, focusing on advanced therapeutic devices to improve patient outcomes.Founded in 1997 and headquartered in Lake Forest, US, Orqis Medical Corporation is dedicated to developing technologies for heart failure treatment. The company experienced a pivotal business strategy shift in 2007 during its Series D funding round, raising USD 12 mn from investors such as Boston Scientific and Johnson & Johnson Innovation. Orqis has successfully completed a total of 4 deals, with the most recent occurring on March 26, 2007. The founder's background is not detailed in the available information.Orqis Medical Corporation provides advanced medical devices aimed at heart failure treatment. Their product offerings focus on innovative therapeutic solutions designed to enhance patient care and management of cardiac conditions, catering to healthcare providers and patients across various medical settings.Orqis Medical's revenue model is primarily driven by the sales of its medical devices and related solutions. The company does not publicly disclose specific financial figures; however, it continues to develop and market its products in the healthcare sector, aiming to meet the growing demand for effective heart failure treatments.Orqis Medical Corporation's strategic growth plan includes advancing the development of its innovative heart failure devices, with expectations to introduce new product lines in the coming years. The recent Series D funding round, which closed in March 2007 with USD 12 mn raised, will support these product development initiatives and expansion into new markets. The company is targeting expansion efforts in North America and Europe by 2025 to enhance its global reach and better serve the healthcare community.

## Funding rounds

- Series D, Mar 26, 2007, $12M — Care Capital, Domain Associates, RHO, EPIC Ventures, Lighthouse Capital Partners, Boston Scientific, Johnson & Johnson Innovation, Cross Creek, Omega Funds, Wasatch Global Investors
- Series D, Jun 22, 2005, $23M — Domain Associates, Lighthouse Capital Partners, Johnson & Johnson Innovation, Boston Scientific Ventures
- Series C, Jun 25, 2003, $25M — Care Capital, Domain Associates, HealthCare Ventures, RHO, Temasek Holdings, Johnson & Johnson Innovation

## Investors

- Care Capital (https://capitalatlas.ai/funds/care-capital) — Series C, Series D
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series C, Series D
- HealthCare Ventures — Series C
- RHO (https://capitalatlas.ai/funds/rho) — Series C, Series D
- Temasek Holdings — Series C
- Johnson & Johnson Innovation (https://capitalatlas.ai/funds/johnson-johnson-innovation) — Series C, Series D
- Lighthouse Capital Partners — Series D
- Boston Scientific Ventures (https://capitalatlas.ai/funds/boston-scientific-ventures) — Series D
- EPIC Ventures (https://capitalatlas.ai/funds/epic-ventures) — Series D
- Boston Scientific — Series D
- Cross Creek (https://capitalatlas.ai/funds/cross-creek) — Series D
- Omega Funds (https://capitalatlas.ai/funds/omega-funds) — Series D
- Wasatch Global Investors — Series D